Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
Krzysztof Kaliszewski, Maksymilian Ludwig, Maria Greniuk, et al.
Cancers (2022) Vol. 14, Iss. 8, pp. 2028-2028
Open Access | Times Cited: 10

Showing 10 citing articles:

Update on the Diagnosis and Management of Medullary Thyroid Cancer: What Has Changed in Recent Years?
Krzysztof Kaliszewski, Maksymilian Ludwig, Bartłomiej Ludwig, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3643-3643
Open Access | Times Cited: 35
Prognostic Impact of Phenotypic and Genetic Features of Pancreatic Malignancies
M. B. Potievskiy, Lidia A. Nekrasova, Ivan V. Korobov, et al.
Life (2025) Vol. 15, Iss. 4, pp. 635-635
Open Access
Virus-associated neuroendocrine cancers: Pathogenesis and current therapeutics
Juni Banerjee, Ramya P. Ranjan, Md Tanjim Alam, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154720-154720
Closed Access | Times Cited: 2
Advances in Endoscopic Diagnosis and Treatment of Gastric Neuroendocrine Neoplasms
Xinrui Guo, Xiaohan Zhao, Gang Huang, et al.
Digestive Diseases and Sciences (2023) Vol. 69, Iss. 1, pp. 27-35
Closed Access | Times Cited: 2
Efficacy of first-line chemotherapy based on primary site of tumor versus etoposide-platinum in advanced gastroenteropancreatic neuroendocrine carcinoma
Haoyang Shen, Yunru Gu, Yuan Fang, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 3, pp. 921-930
Open Access
The challenge of diagnosing neuroendocrine neoplasms: experience from a national reference center
Xixi Zeng, Mengke Ma, Cong Tan, et al.
Virchows Archiv (2024) Vol. 485, Iss. 6, pp. 1021-1031
Closed Access
Possible changes in glucose metabolism induced by radioligand therapy in patients with neuroendocrine neoplasms
Marek Saracyn, Adam Daniel Durma, Barbara Bober, et al.
Endokrynologia Polska (2024) Vol. 75, Iss. 6, pp. 665-671
Open Access
Updates on Diagnostic and Therapeutic Management of Gastrointestinal and Pancreatic NET
Sebastian Krug, Jörg Schrader, Anja Rinke
Cancers (2022) Vol. 14, Iss. 11, pp. 2628-2628
Open Access | Times Cited: 2
Synchronous duodenal neuroendocrine neoplasm and congenital factor XIII deficiency: case report and review of the literature
Lei Shen, Lu Kong, Qi Zhuo, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 16, pp. 913-913
Open Access | Times Cited: 1
Modern opportunities and problematic aspects of diagnostics and treatment of patients with neuroendocrine tumors
M. V. Lysanyuk, П. Н. Ромащенко, Н. А. Майстренко
Perm Medical Journal (2022) Vol. 39, Iss. 5, pp. 58-68
Open Access | Times Cited: 1
Page 1

Scroll to top